Lattice Semiconductor Corporation (LSCC) Drops 5.77% on February 02

Equities Staff |

Lattice Semiconductor Corporation (LSCC) was one of the Russell 2000's biggest losers for Tuesday February 02 as the stock slid 5.77% to $4.57, a loss of $-0.28 per share. Starting at an opening price of $4.80 a share, the stock traded between $4.51 and $4.90 over the course of the trading day. Volume was 772,605 shares over 4,018 trades, against an average daily volume of 2.79 million shares and a total float of 117.91 million.

The losses send Lattice Semiconductor Corporation down to a market cap of $538.83 million. In the last year, Lattice Semiconductor Corporation has traded between $7.30 and $3.25, and its 50-day SMA is currently $5.65 and 200-day SMA is $5.28.

Lattice Semiconductor Corp designs, develops and markets programmable logic products and related software. It also provides design services, customer training, field engineering and technical support.

Lattice Semiconductor Corporation is based out of Hillsboro, OR and has some 784 employees. Its CEO is Darin G. Billerbeck.

For a complete fundamental analysis analysis of Lattice Semiconductor Corporation, check out Equities.com’s Stock Valuation Analysis report for LSCC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…